Exercise-induced hematuria exacerbated by improper hydration, low RBC MCV and dapagliflozin use

Dapagliflozin is a reversible, highly potent, and selective Sodium-Glucose Co-Transporter-2 inhibitor indicated for the treatment of type 2 diabetes. It is generally well tolerated, with a low risk of hypoglycaemia and diabetic ketoacidosis. We report a new adverse effect of dapagliflozin in a form...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2023-11, Vol.167, p.115496-115496, Article 115496
Hauptverfasser:	Sein Anand, Łukasz, Schetz, Daria, Sein Anand, Jacek
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse drug reaction Dapagliflozin Hematuria SLGT2 inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!